Annual CFI
$38.28 M
+$136.10 M+139.13%
December 31, 2024
Summary
- As of March 12, 2025, COGT annual cash flow from investing activities is $38.28 million, with the most recent change of +$136.10 million (+139.13%) on December 31, 2024.
- During the last 3 years, COGT annual CFI has risen by +$39.99 million (+2326.64%).
- COGT annual CFI is now at all-time high.
Performance
COGT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$61.67 M
+$1.49 M+2.47%
December 31, 2024
Summary
- As of March 12, 2025, COGT quarterly cash flow from investing activities is $61.67 million, with the most recent change of +$1.49 million (+2.47%) on December 31, 2024.
- Over the past year, COGT quarterly CFI has stayed the same.
- COGT quarterly CFI is now at all-time high.
Performance
COGT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$38.28 M
+$51.18 M+396.58%
December 31, 2024
Summary
- As of March 12, 2025, COGT TTM cash flow from investing activities is $38.28 million, with the most recent change of +$51.18 million (+396.58%) on December 31, 2024.
- Over the past year, COGT TTM CFI has stayed the same.
- COGT TTM CFI is now -20.03% below its all-time high of $47.86 million, reached on June 30, 2019.
Performance
COGT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
COGT Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +139.1% | 0.0% | 0.0% |
| 3 y3 years | +2326.6% | 0.0% | 0.0% |
| 5 y5 years | +65.3% | +100.0% | +10000.0% |
COGT Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +130.7% | at high | +140.7% | at high | +123.4% |
| 5 y | 5-year | at high | +130.7% | at high | +140.7% | at high | +123.4% |
| alltime | all time | at high | +130.7% | at high | +140.7% | -20.0% | +123.4% |
Cogent Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $38.28 M(-139.1%) | $61.67 M(+2.5%) | $38.28 M(-396.6%) |
| Sep 2024 | - | $60.19 M(-171.1%) | -$12.91 M(-92.1%) |
| Jun 2024 | - | -$84.63 M(-8205.8%) | -$163.63 M(+4.4%) |
| Mar 2024 | - | $1.04 M(-90.0%) | -$156.66 M(+60.1%) |
| Dec 2023 | -$97.82 M(-21.6%) | $10.49 M(-111.6%) | -$97.82 M(+22.4%) |
| Sep 2023 | - | -$90.54 M(+16.6%) | -$79.90 M(-43.3%) |
| Jun 2023 | - | -$77.66 M(-229.7%) | -$140.91 M(+118.8%) |
| Mar 2023 | - | $59.88 M(+110.8%) | -$64.39 M(-48.4%) |
| Dec 2022 | -$124.72 M(+7155.3%) | $28.41 M(-118.7%) | -$124.72 M(-18.8%) |
| Sep 2022 | - | -$151.54 M(>+9900.0%) | -$153.56 M(+4727.5%) |
| Jun 2022 | - | -$1.14 M(+159.4%) | -$3.18 M(+47.3%) |
| Mar 2022 | - | -$441.00 K(+1.8%) | -$2.16 M(+25.7%) |
| Dec 2021 | -$1.72 M(-120.4%) | -$433.00 K(-62.8%) | -$1.72 M(+33.7%) |
| Sep 2021 | - | -$1.16 M(+845.5%) | -$1.29 M(-115.5%) |
| Jun 2021 | - | -$123.00 K(<-9900.0%) | $8.30 M(-1.5%) |
| Mar 2021 | - | $0.00(0.0%) | $8.42 M(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $8.42 M(-63.6%) | $0.00(-100.0%) | $8.42 M(+0.2%) |
| Sep 2020 | - | $8.42 M(>+9900.0%) | $8.41 M(+3846.9%) |
| Jun 2020 | - | $0.00(-100.0%) | $213.00 K(-99.1%) |
| Dec 2019 | $23.16 M(-319.9%) | -$13.00 K(-105.8%) | $23.16 M(-39.3%) |
| Sep 2019 | - | $226.00 K(-97.2%) | $38.17 M(-20.2%) |
| Jun 2019 | - | $8.00 M(-46.5%) | $47.86 M(-3278.0%) |
| Mar 2019 | - | $14.95 M(-0.3%) | -$1.51 M(-85.7%) |
| Dec 2018 | -$10.53 M(-177.5%) | $15.00 M(+51.3%) | -$10.53 M(-49.0%) |
| Sep 2018 | - | $9.91 M(-124.0%) | -$20.63 M(-16.9%) |
| Jun 2018 | - | -$41.37 M(-798.2%) | -$24.82 M(-222.1%) |
| Mar 2018 | - | $5.92 M(+20.9%) | $20.33 M(+49.6%) |
| Dec 2017 | $13.59 M(-144.7%) | $4.90 M(-14.4%) | $13.59 M(+56.4%) |
| Sep 2017 | - | $5.72 M(+51.3%) | $8.69 M(+193.2%) |
| Jun 2017 | - | $3.78 M(-561.3%) | $2.96 M(-461.3%) |
| Mar 2017 | - | -$820.00 K | -$820.00 K |
| Dec 2016 | -$30.43 M(+836.6%) | - | - |
| Dec 2015 | -$3.25 M | - | - |
FAQ
- What is Cogent Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Cogent Biosciences?
- What is Cogent Biosciences annual CFI year-on-year change?
- What is Cogent Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cogent Biosciences?
- What is Cogent Biosciences quarterly CFI year-on-year change?
- What is Cogent Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cogent Biosciences?
- What is Cogent Biosciences TTM CFI year-on-year change?
What is Cogent Biosciences annual cash flow from investing activities?
The current annual CFI of COGT is $38.28 M
What is the all time high annual CFI for Cogent Biosciences?
Cogent Biosciences all-time high annual cash flow from investing activities is $38.28 M
What is Cogent Biosciences annual CFI year-on-year change?
Over the past year, COGT annual cash flow from investing activities has changed by +$136.10 M (+139.13%)
What is Cogent Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of COGT is $61.67 M
What is the all time high quarterly CFI for Cogent Biosciences?
Cogent Biosciences all-time high quarterly cash flow from investing activities is $61.67 M
What is Cogent Biosciences quarterly CFI year-on-year change?
Over the past year, COGT quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Cogent Biosciences TTM cash flow from investing activities?
The current TTM CFI of COGT is $38.28 M
What is the all time high TTM CFI for Cogent Biosciences?
Cogent Biosciences all-time high TTM cash flow from investing activities is $47.86 M
What is Cogent Biosciences TTM CFI year-on-year change?
Over the past year, COGT TTM cash flow from investing activities has changed by $0.00 (0.00%)